Home Services Clinical Affairs

Clinical Affairs

 

Clinical Affairs

 

Pre-IND Program Evaluation and Development, Clinical Development Planning,
Pre-IND meetings, IND services and filings, Phase I - IV Program Development
and Management, Protocol Design, Intelligent CRF Design, Scientific and Medical
Writing Services, Strategy and Design Meetings with Regulatory Agencies,
Pre-Launch Activities, Investigator Meetings, Focus Groups, Branding &
Positioning Activities, Drug Development Business Model Deployment, IRB
Management, Contract & Grant Negotiation and Management Services, Clinical
Trial Instructional Assistance, Opinion Leader Modeling and Positioning.

Synergy can independently manage and monitor your clinical trial, or work  as a
team with the sponsor's team as a true extension of existing research personnel.  
We have and are conducting clinical protocols in over 300 US centers, as well as
30 international research institutions.  Foreign protocols include France, Russia,
Germany, Israel, Canada.

Synergy places a great emphasis on the use of state-of-the-art technologies to
facilitate clinical trial management and monitoring.  Speak to us about real-time
monitoring strategies that can save time and money for your program.

 

 

 

 

Synergy Research Israel Based Clinical Trials

 

 

 

News & Events

  • Pending Litigation to Delay Launch of Generic Asacol Boehringer Ingelheim’s Roxane Laboratori... Read more>>
  • FDA Approves Mylan’s Drug Applications Mylan Inc. Monday announced that its subsidiary Mylan Ph... Read more>>
  • GSK Receives EMEA Approval for Duodart LONDON (AP) - Pharmaceutical company GlaxoSmithKline... Read more>>
  • in vivo Pharmacodynamic Assay Trevigen offers a validated assay with higher sensitivity and... Read more>>
  • Key Protein Aids In DNA Repair Scientists have shown in multiple contexts that DNA damage ov... Read more>>
  • T Cell Proliferation Assays ProImmune Ltd, a leader in epitope discovery, immunogenicity, an... Read more>>
  • U.S. Food & Drug Administration (FDA) New and Generic Drug Approvals Calan (verapamil h... Read more>>
  • Proximagen Signs Deal With Upsher-Smith Proximagen Neuroscience plc, a biotechnology company... Read more>>
  • FDA Says Additional Pixuvri Trial Needed, CTI Opens Drug to Expanded Access Cell Therapeutics... Read more>>
  • Food and Drug Administration NOTICES Meetings:   Internationa... Read more>>
  • Statins May Slow Progression Of Multiple Sclerosis, New Study Finds A UCSF-led study exa... Read more>>
  • AllTranz Developing Multi-Use Transdermal Patch   AllTranz, Lexington, Ky., is focused on t... Read more>>